Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Journal of Clinical Medicine|April 12, 2022
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and ConsJan Torzewski, Patrizia Brunner, Wolfgang Ries, et al.Clinical Research in Cardiology Supplements|February 13, 2015
Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular diseaseFranz Heigl, Reinhard Hettich, Norbert Lotz, et al.Atherosclerosis. Supplements|May 5, 2015
Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in GermanyFranz Heigl, Reinhard Hettich, Norbert Lotz, et al.Therapeutic Advances in Neurological Disorders|February 10, 2023
Immunoadsorption as maintenance therapy for refractory neuromyelitis optica spectrum disorderFranz Heigl, Reinhard Hettich, Cordula Fassbender, et al.Clinical Research in Cardiology Supplements|February 6, 2015
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levelsVolker J J Schettler, Class L Neumann, Christian Peter, et al.The American Journal of Case Reports|July 15, 2020
First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 InfectionJan Torzewski, Franz Heigl, Oliver Zimmermann, et al.Journal of Clinical Apheresis|January 31, 2019
Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis opticaMark Lipphardt, Johannes Mühlhausen, Bernd Kitze, et al.Atherosclerosis. Supplements|February 5, 2010
Indication and implementation of lipidapheresis, rheopheresis, or immunoadsorption (lessons learnt from Germany's largest apheresis center)Franz Heigl, Reinhard Hettich, Norbert Lotz, et al.Atherosclerosis. Supplements|December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresisReinhard Klingel, Franz Heigl, Volker Schettler, et al.Atherosclerosis. Supplements|May 5, 2015
First data from the German Lipoprotein Apheresis Registry (GLAR)Volker J J Schettler, Class L Neumann, Christian Peter, et al.Pageof 4